Insiders · Profile

Ceesay Abraham

Chief Executive Officer at Rapport Therapeutics · Director at Pacira BioSciences. Filing since 4 Sep 2025. CIK 0001722140

Company
Date
Role
Action
Shares
Amount
Of holding
7 Oct 2026
Chief Executive Officer
Sold on a plan
1,147
$35.17K
0.3%
6 Oct 2026
Chief Executive Officer
Sold on a plan
3,375
$108.11K
0.7%
23 Sep 2026
Chief Executive Officer
Sold on a plan
2,210
$86.57K
0.5%
8 Sep 2026
Chief Executive Officer
Sold on a plan
8,210
$374.50K
1.8%
25 Aug 2026
Chief Executive Officer
Sold on a plan
18,921
$937.96K
3.9%
11 Aug 2026
Chief Executive Officer
Sold on a plan
28,958
$1.39M
5.6%
10 Aug 2026
Chief Executive Officer
Sold on a plan
22,541
$1.04M
4.2%
27 Jul 2026
Chief Executive Officer
Sold on a plan
2,210
$93.06K
0.4%
14 Jul 2026
Chief Executive Officer
Sold on a plan
8,210
$328.44K
1.5%
29 Jun 2026
Chief Executive Officer
Sold on a plan
8,220
$327.40K
1.5%
18 Feb 2026
Chief Executive Officer
Sold on a plan
5,833
$171.16K
1.0%
18 Feb 2026
Chief Executive Officer
Sold on a plan
5,083
$149.21K
19.7%
20 Jan 2026
Chief Executive Officer
Sold on a plan
5,833
$152.33K
1.0%
20 Jan 2026
Chief Executive Officer
Sold on a plan
5,083
$132.74K
16.5%
17 Dec 2025
Chief Executive Officer
Sold on a plan
5,833
$172.88K
1.0%
17 Dec 2025
Chief Executive Officer
Sold on a plan
5,083
$150.63K
14.1%
17 Nov 2025
Chief Executive Officer
Sold on a plan
5,833
$146.93K
1.0%
17 Nov 2025
Chief Executive Officer
Sold on a plan
5,083
$128.12K
12.4%
15 Oct 2025
Chief Executive Officer
Sold on a plan
5,833
$150.54K
1.0%
15 Oct 2025
Chief Executive Officer
Sold on a plan
5,083
$131.19K
11.0%
17 Sep 2025
Chief Executive Officer
Sold on a plan
40,835
$1.07M
6.5%
17 Sep 2025
Chief Executive Officer
Sold on a plan
35,585
$936.47K
43.5%
4 Sep 2025
Director
Sold on a plan
2,354
$64.01K
20.7%
23 decisions on file.